{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:19:28Z","timestamp":1767169168040,"version":"build-2238731810"},"reference-count":36,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangzhou Women and Children\u2019s Medical Center","award":["GWCMC2020-4-010"],"award-info":[{"award-number":["GWCMC2020-4-010"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:p>\n                    Backgroud. Preeclampsia (PE) is a critical type of hypertensive disorder of pregnancy, which seriously affects maternal and infant health. The etiology of PE is unclear, and there is no clear prediction model. In this study, new biomarkers were identified before 20 weeks of gestation to construct an early PE prediction model. Purpose. To identify novel biomarker insulin-like growth factor binding protein-2 (IGFBP-2) associated with preeclampsia (PE) before 20 weeks of gestation and to explore the predictive value of plasma IGFBP-2 in PE. Methods. A prospective nested case-control investigation involving 122 PE patients and 122 normal controls (NC) that were matched 1\u2009:\u20091 in terms of age and week of pregnancy was carried out in Guangzhou Women and Children\u2019s Medical Center (Guangzhou, China, 2018030306) from April 2016 to December 2019. At 8 to 20 weeks, blood samples from the mother were taken. To calculate the correlations, univariate conditional logistic regression was employed. Results. Herein, 12 clinical indices were significantly different between the PE and NC groups (uric acid (UA), cystatin C (Cys C), aspartate aminotransferase (AST), glutamyl transpeptidase (\u03b3-GT), total bilirubin (TB), prothrombin time (PT), red blood cell (RBC), hematocrit (HCT), red cell distribution width (RDW), platelets (PLT), mean platelet volume (MPV), and thrombocytocrit (PCT)). Compared with the NC group (\n                    <jats:inline-formula>\n                      <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mn>36.79<\/a:mn>\n                        <a:mo>\u00b1<\/a:mo>\n                        <a:mn>19.91<\/a:mn>\n                      <\/a:math>\n                    <\/jats:inline-formula>\n                    \u2009pg\/mL), the expression level of IGFBP2 in the PE group (\n                    <jats:inline-formula>\n                      <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mn>19.76<\/c:mn>\n                        <c:mo>\u00b1<\/c:mo>\n                        <c:mn>19.40<\/c:mn>\n                      <\/c:math>\n                    <\/jats:inline-formula>\n                    \u2009pg\/mL) before 20 weeks of pregnancy was significantly decreased (\n                    <jats:inline-formula>\n                      <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.01<\/e:mn>\n                      <\/e:math>\n                    <\/jats:inline-formula>\n                    ). Two high-risk factors were found to be significantly associated with PE independently of confounders: anemia 4.35 (2.20-8.45) (\n                    <jats:inline-formula>\n                      <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.01<\/g:mn>\n                      <\/g:math>\n                    <\/jats:inline-formula>\n                    ) and cesarean section history 8.25 (2.67-26.67) (\n                    <jats:inline-formula>\n                      <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&lt;<\/i:mo>\n                        <i:mn>0.01<\/i:mn>\n                      <\/i:math>\n                    <\/jats:inline-formula>\n                    ). As a result of the univariate logistic regression analysis, the following three variables were included in the final logistic regression model.:\n                    <jats:inline-formula>\n                      <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>Y<\/k:mi>\n                        <k:mo>=<\/k:mo>\n                        <k:mo>\u2212<\/k:mo>\n                        <k:mn>18.841<\/k:mn>\n                        <k:mo>\u2212<\/k:mo>\n                        <k:mn>0.085<\/k:mn>\n                        <k:mo>\u00d7<\/k:mo>\n                        <k:mfenced open=\"(\" close=\")\">\n                          <k:mrow>\n                            <k:mtext>IGFBP<\/k:mtext>\n                            <k:mo>\u2010<\/k:mo>\n                            <k:mn>2<\/k:mn>\n                          <\/k:mrow>\n                        <\/k:mfenced>\n                        <k:mo>+<\/k:mo>\n                        <k:mn>0.630<\/k:mn>\n                        <k:mo>\u00d7<\/k:mo>\n                        <k:mfenced open=\"(\" close=\")\">\n                          <k:mrow>\n                            <k:mtext>RDW<\/k:mtext>\n                          <\/k:mrow>\n                        <\/k:mfenced>\n                        <k:mo>+<\/k:mo>\n                        <k:mn>0.165<\/k:mn>\n                        <k:mo>\u00d7<\/k:mo>\n                        <k:mfenced open=\"(\" close=\")\">\n                          <k:mrow>\n                            <k:mtext>AST<\/k:mtext>\n                          <\/k:mrow>\n                        <\/k:mfenced>\n                        <k:mo>+<\/k:mo>\n                        <k:mn>0.863<\/k:mn>\n                        <k:mo>\u00d7<\/k:mo>\n                        <k:mfenced open=\"(\" close=\")\">\n                          <k:mrow>\n                            <k:mtext>MPV<\/k:mtext>\n                          <\/k:mrow>\n                        <\/k:mfenced>\n                      <\/k:math>\n                    <\/jats:inline-formula>\n                    . In comparison to IGFBP-2 alone as an independent predictor of PE (\n                    <jats:inline-formula>\n                      <u:math xmlns:u=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <u:mtext>AUC<\/u:mtext>\n                        <u:mo>=<\/u:mo>\n                        <u:mn>0.897<\/u:mn>\n                      <\/u:math>\n                    <\/jats:inline-formula>\n                    , 95% CI 0.830\u20130.964), the model\u2019s discriminatory power was considerably higher (\n                    <jats:inline-formula>\n                      <w:math xmlns:w=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\">\n                        <w:mtext>AUC<\/w:mtext>\n                        <w:mo>=<\/w:mo>\n                        <w:mn>0.953<\/w:mn>\n                      <\/w:math>\n                    <\/jats:inline-formula>\n                    , 95% CI 0.911\u20130.995). Conclusion. Plasma IGFBP-2 before 20 weeks of pregnancy combined with high-risk factors and routine blood indexes has a high early predictive value for PE.\n                  <\/jats:p>","DOI":"10.1155\/2022\/5075569","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T18:35:12Z","timestamp":1664390112000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Value of IGFBP-2 in Predicting Preeclampsia before 20 Weeks of Pregnancy: A Prospective Nested Case-Control Study"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-2431","authenticated-orcid":true,"given":"Fei","family":"Gao","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"},{"name":"Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"},{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaye","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sufei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenting","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jielin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou Women and Children\u2019s Medical Center, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-4731","authenticated-orcid":true,"given":"Wen","family":"Wang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"},{"name":"Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-8780","authenticated-orcid":true,"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"},{"name":"Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1097\/NMC.0000000000000523"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12802"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32335-7"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319101"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.11.1087"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.01.020"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23645"},{"issue":"4","key":"9","first-page":"229","article-title":"Preeclampsia - a disease of pregnant women","volume":"64","author":"A. Filipek","year":"2018","journal-title":"Postepy Biochemii"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000942"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.777152"},{"key":"12","volume-title":"The insulin-like growth factor binding proteins (IGFBPs) and their role in the regulation of human chondrocyte growth","author":"S. Mehmet","year":"2000"},{"issue":"17","key":"13","first-page":"4228","article-title":"Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling","volume":"59","author":"G. N. Fuller","year":"1999","journal-title":"Cancer Research"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1159\/000303260"},{"key":"15","first-page":"8","article-title":"Guidelines for diagnosis and treatment of hypertension in pregnancy (2015)","volume":"10","author":"Z. Yang","year":"2015","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S309725"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03596-4"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280757.Epub"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4680"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01865-8"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01907-1"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212195"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02042-7"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.11.1356"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.10.023"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-019-0119-7"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12041011"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102714"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2011.01311.x"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1572737"},{"issue":"7","key":"31","first-page":"1015","article-title":"Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"27","author":"S. C. Demir","year":"2006","journal-title":"Saudi Medical Journal"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0861-3"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0006322020"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020447"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12479"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1002\/uog.11205"}],"updated-by":[{"DOI":"10.1155\/2023\/9837874","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"record-id":"59863"},{"DOI":"10.1155\/2023\/9837874","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000}}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5075569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5075569.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5075569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T18:35:28Z","timestamp":1664390128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/5075569\/"}},"subtitle":[],"editor":[{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":36,"alternative-id":["5075569","5075569"],"URL":"https:\/\/doi.org\/10.1155\/2022\/5075569","relation":{},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}